000			02156 a2200565 4500
005			20250514050733.0
264		0	_c20021209
008			200212s 0 0 eng d
022			_a0002-9149
024	7		_a10.1016/s0002-9149(02)02653-x _2doi
040			_aNLM _beng _cNLM
100	1		_aIslam, M Ashequl
245	0	0	_aEffect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT). _h[electronic resource]
260			_bThe American journal of cardiology _cNov 2002
300			_a916-21 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAbciximab
650	0	4	_aAngioplasty, Balloon, Coronary
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aBlood Vessel Prosthesis Implantation
650	0	4	_aCoronary Angiography _xadverse effects
650	0	4	_aCreatine Kinase _xblood
650	0	4	_aCreatine Kinase, MB Form
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Evaluation
650	0	4	_aEndpoint Determination
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Fab Fragments _xtherapeutic use
650	0	4	_aIncidence
650	0	4	_aIsoenzymes _xblood
650	0	4	_aMale
650	0	4	_aMyocardial Ischemia _xepidemiology
650	0	4	_aNorth America _xepidemiology
650	0	4	_aPlatelet Aggregation Inhibitors _xtherapeutic use
650	0	4	_aPlatelet Glycoprotein GPIIb-IIIa Complex _xtherapeutic use
650	0	4	_aStents
650	0	4	_aSurvival Analysis
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aBlankenship, James C
700	1		_aBalog, Craig
700	1		_aIliadis, Elias A
700	1		_aLincoff, A Michael
700	1		_aTcheng, James E
700	1		_aCaliff, Robert M
700	1		_aTopol, Eric J
773	0		_tThe American journal of cardiology _gvol. 90 _gno. 9 _gp. 916-21
856	4	0	_uhttps://doi.org/10.1016/s0002-9149(02)02653-x _zAvailable from publisher's website
999			_c12207613 _d12207613